These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22898077)

  • 1. Sex differences in HDL ApoC-III in American Indian youth.
    Blackett PR; Khan S; Wang W; Alaupovic P; Lee ET
    Biol Sex Differ; 2012 Aug; 3(1):18. PubMed ID: 22898077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth.
    Blackett PR; Blevins KS; Quintana E; Stoddart M; Wang W; Alaupovic P; Lee ET
    Metabolism; 2005 Feb; 54(2):180-7. PubMed ID: 15690311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
    Chan DC; Nguyen MN; Watts GF; Barrett PH
    J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.
    Wang W; Khan S; Blackett P; Alaupovic P; Lee E
    J Clin Lipidol; 2013; 7(1):38-42. PubMed ID: 23351581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
    Yamamoto R; Sacks FM; Hu FB; Rosner B; Furtado JD; Aroner SA; Ferrannini E; Baldi S; Kozakova M; Balkau B; Natali A; Jensen MK;
    Atherosclerosis; 2018 Feb; 269():92-99. PubMed ID: 29351856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
    Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
    Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
    Jensen MK; Aroner SA; Mukamal KJ; Furtado JD; Post WS; Tsai MY; Tjønneland A; Polak JF; Rimm EB; Overvad K; McClelland RL; Sacks FM
    Circulation; 2018 Mar; 137(13):1364-1373. PubMed ID: 29162611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes.
    Krishnan S; Shimoda M; Sacchi R; Kailemia MJ; Luxardi G; Kaysen GA; Parikh AN; Ngassam VN; Johansen K; Chertow GM; Grimes B; Smilowitz JT; Maverakis E; Lebrilla CB; Zivkovic AM
    Sci Rep; 2017 Mar; 7():43728. PubMed ID: 28287093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
    J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.
    Cohn JS; Batal R; Tremblay M; Jacques H; Veilleux L; Rodriguez C; Mamer O; Davignon J
    J Lipid Res; 2003 Oct; 44(10):1976-83. PubMed ID: 12867543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk.
    Aroner SA; Yang M; Li J; Furtado JD; Sacks FM; Tjønneland A; Overvad K; Cai T; Jensen MK
    Am J Epidemiol; 2017 Sep; 186(6):736-744. PubMed ID: 28520887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and high-density lipoproteins in Cherokee Indian children and adolescents.
    Blackett PR; Blevins KS; Stoddart M; Wang W; Quintana E; Alaupovic P; Lee ET
    Pediatr Res; 2005 Sep; 58(3):472-7. PubMed ID: 16148059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III.
    Koch M; Furtado JD; Jiang GZ; Gray BE; Cai T; Sacks F; Tjønneland A; Overvad K; Jensen MK
    J Lipid Res; 2017 Jun; 58(6):1196-1203. PubMed ID: 28365588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL.
    Cho KH
    Mol Cells; 2009 Mar; 27(3):291-7. PubMed ID: 19326075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis).
    Aroner SA; Koch M; Mukamal KJ; Furtado JD; Stein JH; Tattersall MC; McClelland RL; Jensen MK
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29540426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
    Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
    Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.